Condition

Relapsed Osteosarcoma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Relapsed Osteosarcoma clinical trials that are recruiting, in United States. By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Relapsed Osteosarcoma clinical trials

StudyPhaseWhereStatusRegistered
NKG2D.zeta-NK cells plus C7R.GD2.CAR-T cells for relapsed or refractory neuroblastoma or osteosarcoma Phase 1 Houston, Texas Recruiting Oct 8, 2025
Tegavivint plus gemcitabine for relapsed or refractory osteosarcoma Phase 1 Atlanta, Georgia and 1 other locations Recruiting Aug 27, 2025
Using expanded gamma delta T cells with chemotherapy for treating relapsed neuroblastoma and osteosarcoma Phase 1 Atlanta, Georgia Recruiting Jun 1, 2022

All recruiting trials (3)

Related topics

Refractory OsteosarcomaRefractory NeuroblastomaRelapsed NeuroblastomaNeuroblastomaOsteosarcoma in ChildrenOsteosarcoma RecurrentCAR-TDinutuximab

Quick answers

How many Relapsed Osteosarcoma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.